Carbon-based polymeric nanocomposite hydrogels (NCHs) represent a groundbreaking advancement in biomedical materials by integrating nanoparticles such as graphene, carbon nanotubes (CNTs), carbon dots (CDs), and activated charcoal (AC) into polymeric matrices. These nanocomposites significantly enhance the mechanical strength, electrical conductivity, and bioactivity of hydrogels, making them highly effective for drug delivery, tissue engineering (TE), bioinks for 3D Bioprinting, and wound healing applications. Graphene improves the mechanical and electrical properties of hydrogels, facilitating advanced tissue scaffolding and drug delivery systems. CNTs, with their exceptional mechanical strength and conductivity, enhance rheological properties, facilitating their use as bioinks in supporting complex 3D bioprinting tasks for neural, bone, and cardiac tissues by mimicking the natural structure of tissues. CDs offer fluorescence capabilities for theranostic applications, integrating imaging and therapeutic functions. AC enhances mechanical strength, biocompatibility, and antibacterial effectiveness, making it suitable for wound healing and electroactive scaffolds. Despite these promising features, challenges remain, such as optimizing nanoparticle concentrations, ensuring biocompatibility, achieving uniform dispersion, scaling up production, and integrating multiple functionalities. Addressing these challenges through continued research and development is crucial for advancing the clinical and industrial applications of these innovative hydrogels.